Vascular endothelial cells are a component of the neural stem cell niche [100], and inhibitors of vascular endothelial growth factor (VEGF) have shown promise in ablating CICs, in addition to decreasing tumor vascularization, in a xenograft model of glioblastoma [101]. This evidence concerns the gene VEGFA and glioblastoma.